Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice

Hemophilia A (HA) is a rare bleeding disorder caused by factor VIII (FVIII) deficiency due to various genetic mutations in the F8 gene. The disease severity inversely correlates with the plasma levels of functional FVIII. The treatment of HA patients is based on FVIII replacement therapy, either fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardo, Ángel, Caro, Alberto, Martínez-Carballeira, Daniel, Corte, José Ramón, Vázquez, Sonia, Palomo-Antequera, Carmen, Andreu, Alfredo, Fernández-Pardo, Álvaro, Oto, Julia, Gutiérrez, Laura, Soto, Inmaculada, Medina, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224793/
https://www.ncbi.nlm.nih.gov/pubmed/35743412
http://dx.doi.org/10.3390/jcm11123345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224793/
https://www.ncbi.nlm.nih.gov/pubmed/35743412
http://dx.doi.org/10.3390/jcm11123345

Ejemplares similares